⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers

Official Title: Evaluation of a Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers

Study ID: NCT00376818

Study Description

Brief Summary: RATIONALE: Yoga, meditation, and breathing exercises may help lower stress and improve quality of life in patients with malignant brain tumors and their family caregivers. PURPOSE: This clinical trial is studying how well a stress reduction program works to improve the quality of life of patients with malignant brain tumors and their family caregivers.

Detailed Description: OBJECTIVES: Primary * Determine whether regular practice of a stress reduction program for 8 weeks improves the quality of life of patients with malignant brain tumors. Secondary * Determine whether regular practice of a stress reduction routine decreases perception of stress and anxiety and stress- and inflammation-related hormones in both patients with malignant brain tumors and their primary family caregivers. OUTLINE: This is a pilot study. Patients and caregivers receive a 90-minute stress-reduction session once a week for 8 weeks. Each session comprises an educational session on stress reduction and yoga therapy comprising specific yoga postures, breathing exercises, and relaxation and meditation. Quality of life, stress, anxiety, and levels of stress-related hormones (cortisol, dehydroepiandrosterone sulfate \[DHEAS\], and melatonin) are assessed at baseline and at week 8. After completion of study treatment, patients and caregivers are followed at 6 and 12 months. PROJECTED ACCRUAL: A total of 14 caregiver/patient pairs will be accrued for this study.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

Contact Details

Name: Glen H. J. Stevens, DO, PhD

Affiliation: The Cleveland Clinic

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: